CN1188004A - Gastrointestinal mucosa nutritive protective agent and its preparing technology - Google Patents
Gastrointestinal mucosa nutritive protective agent and its preparing technology Download PDFInfo
- Publication number
- CN1188004A CN1188004A CN97105033A CN97105033A CN1188004A CN 1188004 A CN1188004 A CN 1188004A CN 97105033 A CN97105033 A CN 97105033A CN 97105033 A CN97105033 A CN 97105033A CN 1188004 A CN1188004 A CN 1188004A
- Authority
- CN
- China
- Prior art keywords
- radix
- protective agent
- gastrointestinal mucosa
- nutritive
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a nutritive protective agent for gastrointestinal mucosa and its preparation process. Said protective agent is made up by using ass hide glue, honey-fried astragalus root, codonopsis root, white peony root, cinnamon bark,, bletilla tuber, cuttlefish bone and honey-fried licorice, etc. through such processes of weighing, proportioning, mixing, drying and pulverizing. Said invented protective agent has the function of boosting qi and nourishing stomach, harmonizing qi and blood, improving gastrointestinal function and relieving inflammation and stopping pain.
Description
The present invention relates to a kind of preparation technology who is used to alleviate and treat the Chinese medicine preparation and the patent medicine thereof of gastropathy.
Taste are behaved it " the foundation of acquired constitution ", all diet and the person of going into all belongs to gastrointestinal, and the gastrointestinal normal physiological function is an important step of finishing digestion, has only the diet allotment rationally, could improve the gastrointestinal function, thereby guarantee the abundant absorption of nutrition, increase the vigor of body.Yet, because adding of rhythm of life, the sickness rate of modern's gastrointestinal disease significantly improves, this not only directly has influence on people's life, and affect indirectly aspects such as people's work, but the Therapeutic Method that can adopt basically at present is nothing more than following several: 1. antacid, and as sodium bicarbonate etc.It can be rapidly in and the acidic materials in the gastrointestinal, thereby alleviate the state of an illness, but the heavy dose of and thing that takes this medicine for a long time can cause hyperpyremia, in addition because in and produced a large amount of gas in the process of gastric acid, very easily cause the danger of ulcer surface perforation; Though the magnesium oxide in this type of medicine can not produce a large amount of gas, make time spent generation magnesium chloride at itself and gastric acid, emit magnesium ion, and then cause gastrointestinal diarrhoea; 2. gastric acid secretion inhibitor, the H2-of histamine receptor blocking agent, clinical cimetidine commonly used is blocked parietal cell secretion gastric acid as blocker, stimulates to alleviate its acidity to gastric ulcer; But it has severe impairment to people's Liver and kidney, takes for a long time to cause hematuria, even can cause the burst that hat must be sick; 3. increase the medicine of gastrointestinal mucosa defensive enginery, this type of medicine such as carbenoxolone etc. though it can increase the capacity antacid of gastrointestinal mucosa, are taken for a long time, can cause edema, even disease such as hypertension; 4. anticholinergic agent, Semen daturae tincture, atropine etc., it can alleviate the smooth muscle convulsion pain that gastric ulcer causes, but it also has xerostomia, and blurred vision, Blushing etc. are paid effect.In sum, the at present existing a few class medicines that generally use though can alleviate the symptom of gastric ulcer, are all paid effect with the poison of degree not clinically; In addition, these medicines can only be alleviated the symptom of gastric ulcer, can not effect a radical cure this disease effectively, for people's water is removed ailing disturbing for a long time.
It is good to the objective of the invention is to disclose a kind of therapeutic effect, nontoxic pair of effect, the novel stomach good medicine-gastrointestinal mucosa nutritive protective agent and the preparation technology thereof of controlling for the treatment of both the principal and secondary aspects of a disease.
The present invention seeks to realize like this:
1. composition: (weight portion)
Colla Corii Asini 1.5-5 part, Radix Astragali Mongolici (processed) 1.5-3 part, Radix Codonopsis 1-3 part, Radix Paeoniae Alba 3-4 part, Cortex Cinnamomi 2-3 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 2-4 part, Os Sepiae 1-3 part, Radix Glycyrrhizae Preparata 1-3 part;
2. preparation technology
(1), weighing and burden with above-mentioned composition decontamination after, weigh standby by corresponding weight portion;
(2), oven dry pulverizes with the raw material stoving described in (1), shred, and it is standby to be crushed into 200 order powder;
(3), the dosage form compatibility can be inserted in the capsule by (2) gained powder, also can adopt the pack of shot-blasting machine grit blast, also powder system paulownia ball size can be gone into the bag encapsulation.
Colla Corii Asini in the side is except that the effect that itself has granulation promoting, enriches blood, and it also is used for we's base material; Radix Astragali Mongolici (processed) QI invigorating, granulation promoting are used for antacid; Radix Codonopsis invigorating the spleen and replenishing QI, spleen invigorating, antiulcer; Radix Paeoniae Alba pain relieving, nourish blood, help the recovery of ulcer surface; Cortex Cinnamomi has the effect of stomach warming YANG invigorating, dispersing cold for relieving pain; The Pseudobulbus Bletillae (Rhizoma Bletillae) has nourishing the stomach, granulation promoting, hemostasis, astringent effect; But Os Sepiae antacid and hemostasis; Radix Glycyrrhizae Preparata invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing and all medicines; This side adopts Chinese medical discrimination to cure Design Theory, the QI invigorating nourishing the stomach, and QI and blood regulating is improved gastrointestinal function, and anti-inflammatory analgetic can reach the effect to the gastropathy treating both the principal and secondary aspects of a disease.
Embodiments of the invention are described in detail in detail below.
Embodiment 1 chronic gastritis type
1. composition:
Colla Corii Asini 3g, Radix Astragali Mongolici (processed) 1.5g, Radix Codonopsis 1.5g, Radix Paeoniae Alba 3g, Cortex Cinnamomi 2g, Pseudobulbus Bletillae (Rhizoma Bletillae) 2g, Os Sepiae 2g, Radix Glycyrrhizae Preparata 2g.
2. preparation technology
(1), weighing and burden with above-mentioned composition decontamination after, weigh standby by corresponding weight portion;
(2), oven dry pulverizes with the raw material stoving described in (1), shred, and it is standby to be crushed into 200 order powder;
(3), the dosage form compatibility can be inserted in the capsule by (2) gained powder, also can adopt the pack of shot-blasting machine grit blast, also powder system paulownia ball size can be gone into the bag encapsulation.
Embodiment 2 gastric ulcers and duodenal ulcer
1. composition:
Colla Corii Asini 5g, Radix Astragali Mongolici (processed) 2g, Radix Codonopsis 2g, Radix Paeoniae Alba 3g, Cortex Cinnamomi 3g, Pseudobulbus Bletillae (Rhizoma Bletillae) 3g, Os Sepiae 3g, Radix Glycyrrhizae Preparata 3g.
2. preparation technology is with embodiment 1.
Claims (4)
1. gastrointestinal mucosa nutritive protective agent, it is characterized in that: its composition is: (weight portion)
Colla Corii Asini 1.5-5 part, Radix Astragali Mongolici (processed) 1.5-3 part, Radix Codonopsis 1-3 part, Radix Paeoniae Alba 3-4 part, Cortex Cinnamomi 2-3 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 2-4 part, Os Sepiae 1-3 part, Radix Glycyrrhizae Preparata 1-3 part.
2. prepare the technology of the described gastrointestinal mucosa nutritive protective agent of claim 1, it is characterized in that:
(1), weighing and burden with above-mentioned composition decontamination after, weigh standby by corresponding weight portion;
(2), oven dry pulverizes with the raw material stoving described in (1), shred, and it is standby to be crushed into 200 order powder;
(3), the dosage form compatibility can be inserted in the capsule by (2) gained powder, also can adopt the pack of shot-blasting machine grit blast, also powder system paulownia ball size can be gone into the bag encapsulation.
3. gastrointestinal mucosa nutritive protective agent as claimed in claim 1 is characterized in that: its composition is: Colla Corii Asini 3g, Radix Astragali Mongolici (processed) 1.5g, Radix Codonopsis 1.5g, Radix Paeoniae Alba 3g, Cortex Cinnamomi 2g, Pseudobulbus Bletillae (Rhizoma Bletillae) 2g, Os Sepiae 2g, Radix Glycyrrhizae Preparata 2g.
4. gastrointestinal mucosa nutritive protective agent as claimed in claim 1 is characterized in that: its composition is: Colla Corii Asini 5g, Radix Astragali Mongolici (processed) 2g, Radix Codonopsis 2g, Radix Paeoniae Alba 3g, Cortex Cinnamomi 3g, Pseudobulbus Bletillae (Rhizoma Bletillae) 3g, Os Sepiae 3g, Radix Glycyrrhizae Preparata 3g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97105033A CN1188004A (en) | 1997-01-17 | 1997-01-17 | Gastrointestinal mucosa nutritive protective agent and its preparing technology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97105033A CN1188004A (en) | 1997-01-17 | 1997-01-17 | Gastrointestinal mucosa nutritive protective agent and its preparing technology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1188004A true CN1188004A (en) | 1998-07-22 |
Family
ID=5167595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97105033A Pending CN1188004A (en) | 1997-01-17 | 1997-01-17 | Gastrointestinal mucosa nutritive protective agent and its preparing technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1188004A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088592C (en) * | 1999-08-20 | 2002-08-07 | 高保卫 | Medicine for treating peptic ulcer |
| CN102793097A (en) * | 2012-09-08 | 2012-11-28 | 云南植物药业有限公司 | Health care food with gastric mucous membrane protecting function |
| CN109589386A (en) * | 2017-09-30 | 2019-04-09 | 张雷 | A kind of Chinese medicine for treating gastric and duodenal ulcer |
-
1997
- 1997-01-17 CN CN97105033A patent/CN1188004A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088592C (en) * | 1999-08-20 | 2002-08-07 | 高保卫 | Medicine for treating peptic ulcer |
| CN102793097A (en) * | 2012-09-08 | 2012-11-28 | 云南植物药业有限公司 | Health care food with gastric mucous membrane protecting function |
| CN109589386A (en) * | 2017-09-30 | 2019-04-09 | 张雷 | A kind of Chinese medicine for treating gastric and duodenal ulcer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN108403937A (en) | It is a kind of to treat dermopathic external traditional Chinese medicine ointment and preparation method thereof | |
| CN111298019B (en) | Traditional Chinese medicine for treating tachyarrhythmia | |
| CN104069162A (en) | Traditional Chinese medicine for treating gouty arthritis and various bone and arthrosis pains | |
| CN1326757A (en) | Medicinal composition for curing protrusion of lumber intervertebral disc | |
| CN1188004A (en) | Gastrointestinal mucosa nutritive protective agent and its preparing technology | |
| CN100450520C (en) | Medicine for treating chronic glomerular nephritis and its producing method | |
| CN1090503A (en) | A kind of adjuvant drug for tumor therapy | |
| CN1237994C (en) | Medicine composition for preparing canker and preparing method thereof | |
| CN1177606C (en) | Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process | |
| CN106822733B (en) | Ointment for treating precancerous lesion of chronic atrophic gastritis and preparation method thereof | |
| CN1150021C (en) | Chinese patent medicine for treating peptic ulcer | |
| CN101327293A (en) | Capsules for treating peptic ulcer and preparation method thereof | |
| CN1259933C (en) | Chinese medicinal composition for treating coronary disease and its preparation and application | |
| CN1194733C (en) | Medicine for treating hyperthyroidism and its prepn | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN1148216C (en) | Medicine for curing acne and sore | |
| CN115252679B (en) | Traditional Chinese medicine composition for treating ischemic cardiomyopathy and application thereof | |
| CN116570699B (en) | Traditional Chinese medicine composition for treating pulmonary nodules as well as preparation and application thereof | |
| CN1074295C (en) | Traditional Chinese medicine Sanfeng anticancer capsule for treating lung cancer and preparation method thereof | |
| CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof | |
| CN106860646B (en) | Traditional Chinese medicine composition for treating gastroduodenal ulcer and preparation method thereof | |
| CN1168483C (en) | Heart disease treating medicine | |
| CN100335108C (en) | Tonifying Chinese medicine for treating tuberculosis | |
| CN1340350A (en) | Chewing medicine for treating facial paralysis and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |